Sterol Biosynthesis Inhibitors: Pharmaceutical and Agrochemical AspectsDieter Berg, Manfred Plempel |
Contents
1 | 20 |
Morpholines | 46 |
Morphological aspects of azole action | 56 |
Copyright | |
30 other sections not shown
Common terms and phrases
accumulation acid activity allylamines amorolfine amphotericin antifungal Antifungal Agents Antimicrob antimycotic application aromatase azole azole antifungals azole compounds azole derivatives barley Bayer Bayleton bifonazole Biochem Candida albicans candidosis cell membrane cereals cerevisiae CH₂ CH3 CH3 cholesterol clinical clotrimazole concentrations Crop cytochrome P-450 disease dose drug EBI fungicides econazole effect efficacy enantiomer enzyme epoxidase ergosterol ergosterol biosynthesis Erysiphe graminis fenpropidin fenpropimorph fluconazole fungal fungi fungicides Fusarium growth imidazole inactivation increased infection inhibition inhibitors itraconazole ketoconazole lanosterol leafspot lipid liver maydis metabolism mg/kg mg/l miconazole microsomes morpholine mycoses naftifine oral pathogens patients peanut Pestic plant plasma powdery mildew Proc Pyrenophora resistance Rhynchosporium secalis Septoria species spectrum spray squalene sterol biosynthesis studies substrate synthesis Systemic properties Table terbinafine therapy treated treatment triadimefon triazole tridemorph triforine Ustilago vaginal Vanden Bossche vibunazole vitro vivo wheat yeast zole µg/ml